Assessment of Unilateral Biportal Endoscopy Technique Applied to Treatment of Degenerative Lumbar Pathologies
UBEVAL
1 other identifier
observational
500
1 country
1
Brief Summary
Lumbar disc herniation (HDL) is one of the main causes for low back pain and sciatica. Although non surgical care remains the gold standard as first treatment, lumbar discectomy is used to effectively relieve symptoms that persist for prolonged periods. With surgical techniques evolution, minimally invasive spine surgery has emerged in recent decades as an alternative to conventional open surgery and is widely used for HDL treatment. Several minimally invasive surgical endoscopic techniques have been developed for disc herniation: Single Portal Endoscopy (SE), Video Assisted Endoscopic Discectomy, and recently Unilateral Biportal Endoscopy (UBE). Currently, SE is considered as the minimally invasive surgery gold standard for HDL but, over the past two years, UBE for the treatment of degenerative lumbar diseases has increased exponentially with faster learning curve than other endoscopic techniques. As an emerging technique, further studies are needed to better understand UBE. This is why Dr. Cristini's team wish to analyze a cohort of patients for whom this technique has been used since July 2022, in particular the complication rate. Controlling a new technique requires a learning phase. This is why Dr. Cristini's team also wishes to describe the learning curve on the cohort of patients for whom UBE was used since July 2022.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2024
CompletedFirst Submitted
Initial submission to the registry
June 3, 2024
CompletedFirst Posted
Study publicly available on registry
June 7, 2024
CompletedJune 7, 2024
June 1, 2024
1.8 years
June 3, 2024
June 3, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Patient complication rate
Complications will include epidural hematoma, nerve root injury, neurological deficit, dural breach or tear, incomplete surgery, epileptic crisis, hypothermia. Other complications will be HDL recurrence, pain neuropathy, infection and thromboembolic complications
2 days
Secondary Outcomes (1)
surgeon learning curve
21 months
Study Arms (1)
Unilateral Biportal Endoscopy (UBE) Technique
Patient with LDH treated by UBE
Interventions
Eligibility Criteria
Study population means patients who fulfill inclusion and exclusion criteria
You may qualify if:
- Patient, male or female, over 18 years old
- Patient with lumbar disc herniation or non-instrumented degenerative lumbar pathology
- Patient operated with UBE technique
You may not qualify if:
- Patient with extreme lateral disc herniation.
- Patient suffering from other serious illnesses
- Patient with lumbar instability, lumbar infection or lumbar tumor,
- Patient with multi-segmental lumbar disease requiring treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital CLAIRVAL
Marseille, 13009, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2024
First Posted
June 7, 2024
Study Start
July 1, 2022
Primary Completion
March 31, 2024
Study Completion
March 31, 2024
Last Updated
June 7, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share